SK bioscience Co.,Ltd.(KR:302440)
₩39,000.00-450.00 (-1.14%)
KR:302440
SK bioscience Co.,Ltd. financials statements
₩39,000.00
At close:-450.00 (-1.14%)
Want to see KR:302440 full AI Analyst Report?
SK bioscience Co.,Ltd. (302440) Income Statement
1 Followers
SK bioscience Co.,Ltd. Income Statement
Last quarter (Q2 2026), SK bioscience Co.,Ltd.'s total revenue was ₩155.71B, a decrease of 3.80% from the same quarter last year. In Q2, SK bioscience Co.,Ltd.'s net income was ₩-14.09B. See SK bioscience Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 651.37B | ₩ 267.55B | ₩ 369.51B | ₩ 456.73B | ₩ 929.00B | |
| ₩ 59.49B | ₩ 30.98B | ₩ 141.82B | ₩ 239.61B | ₩ 570.28B | |
| ₩ 210.81B | ₩ 169.41B | ₩ 146.56B | ₩ 124.60B | ₩ 96.06B | |
| Depreciation and Amortization | ₩ 91.02B | ₩ 49.23B | ₩ 34.76B | ₩ 27.24B | ₩ 18.78B |
| ₩ -60.31B | ₩ -36.20B | ₩ 43.49B | ₩ 171.43B | ₩ 493.00B | |
| ₩ -151.33B | ₩ -138.43B | ₩ -4.73B | ₩ 115.01B | ₩ 474.22B | |
| ₩ 65.47B | ₩ 49.32B | ₩ 12.06B | ₩ 26.72B | ₩ -3.09B | |
| ₩ -85.86B | ₩ -89.11B | ₩ 7.33B | ₩ 141.73B | ₩ 471.13B | |
| ₩ -56.17B | ₩ -53.88B | ₩ 22.32B | ₩ 122.45B | ₩ 355.14B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -718.26 | ₩ -700.16 | ₩ 291.00 | ₩ 1596.18 | ₩ 4642.34 |
| Diluted EPS | ₩ -718.26 | ₩ -701.32 | ₩ 289.79 | ₩ 1589.84 | ₩ 4642.34 |
| Weighted Average Shares Outstanding | 78.21M | 77.20M | 76.69M | 76.72M | 76.50M |
| Weighted Average Shares Outstanding (Diluted) | 78.21M | 77.39M | 77.01M | 77.02M | 76.50M |
Currency in KRW

